A case study of a patient in Wuhan, China, suggests that the immunosuppressant tocilizumab may be an effective therapeutic strategy against COVID-19 in infected patients who also have multiple myeloma and other blood cancers.

A sponge found in Manado Bay, Indonesia, synthesizes a molecule called manzamine A, which has been shown to stop the growth of cervical cancer cells. The study explored the anti-growth and cancer cell-killing effects of manzamine A in different cervical cancer cell lines.

An antibody recovered from a survivor of the SARS epidemic in the early 2000s has revealed a potential vulnerability of the new coronavirus at the root of COVID-19, according to a study from scientists at Scripps Research.

Better cumulative decisions in early phases of drug development could lead to a greater chance of clinical success, as the correct dosage can be identified and tested in the right patient populations for the right early indicator. In this article, we delve into the current and future aspects of early-phase oncology trials.

On December 31, 2019, the first cases of a novel coronavirus were identified in Wuhan City, Hubei Province, China. Here, we curate a collection of news and content related to the outbreak.

Technology Networks is committed to keeping you updated with the latest research in this space. Below, you'll find a curation of our latest COVID-19 vaccine-related content.